Dynavax Soars After Sanofi Acquistion; Intel Falls on Report; AST SpaceMobile Rallies
On this episode of Stock Movers:- Shares of Dynavax Technologies (DVAX) soared in premarket trading after Sanofi agreed to buy Dynavax for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesday. The statement on Wednesday came minutes after Sanofi said the US Food and Drug Administration had surprisingly rejected its experimental multiple sclerosis drug tolebrutinib.- Shares of Intel (INTC) fell in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.